1. Home
  2. BCO vs INDV Comparison

BCO vs INDV Comparison

Compare BCO & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brinks Company (The)

BCO

Brinks Company (The)

HOLD

Current Price

$117.26

Market Cap

4.8B

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$40.19

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCO
INDV
Founded
1859
N/A
Country
United States
United States
Employees
125
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.4B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
BCO
INDV
Price
$117.26
$40.19
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$154.00
N/A
AVG Volume (30 Days)
559.7K
1.5M
Earning Date
05-06-2026
06-08-2026
Dividend Yield
0.95%
N/A
EPS Growth
29.20
8100.00
EPS
0.77
0.69
Revenue
$3,562,300,000.00
$1,239,000,000.00
Revenue This Year
$7.22
N/A
Revenue Next Year
$5.92
N/A
P/E Ratio
$153.18
$58.01
Revenue Growth
N/A
4.29
52 Week Low
$85.00
$17.10
52 Week High
$136.37
$42.81

Technical Indicators

Market Signals
Indicator
BCO
INDV
Relative Strength Index (RSI) 63.33 53.00
Support Level $115.21 $38.47
Resistance Level $127.03 $41.42
Average True Range (ATR) 3.65 1.24
MACD 0.66 -0.15
Stochastic Oscillator 69.96 53.60

Price Performance

Historical Comparison
BCO
INDV

About BCO Brinks Company (The)

The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provide BGS services and BGS activity in Latin American countries. It derives maximum revenue from the North America segment.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: